Claritas Pharmaceuticals Inc V.CLAS.H

Alternate Symbol(s): CLAZF

Healthcare

Claritas Pharmaceuticals, Inc., formerly Kalytera Therapeutics Inc, is a biotechnology company that is focused on developing R-107 for the treatment of vaccine-resistant coronavirus disease (COVID) strains. The Company’s products in development include R-107 for coronavirus disease and Viral Infections, R-107 and Vaccines, and CLA-1816 for treatment of pain. R-107 is designed to defeat COVID viruses on contact. R-107 targets the Achilles heel of COVID, the spike protein on the surface of the virus. R-107 releases nitric oxide, which attaches to a specific amino acid on the spike protein, thereby disabling the spike protein. The CLA-1816 provides effective pain reduction, without the risks of addiction or respiratory suppression that exist with opioid analgesics. CLA-1816 strongly binds with and activates the alpha3 glycine pain receptor in the spine. The Company has leased a laboratory, office, and archival space in Beverly, Massachusetts.

TSXV:CLAS.H - Post by User

Claritas Pharmaceuticals Inc > Stock price

<< Previous

Bullboard Posts

Next >>

Post by Raiders11on Nov 30, 2020 3:31pm

840 Views

Post# 32002516

Stock price

We all need to realize this joke if a company was a ponzi scheme,flipping from one company to another to bring in more suckers like myself,they haven't sold a red cent of anything ever,they have no profit whatsoever,they have no future profit whatsoever,they will be to late for their nitrous scam,how can it take months and months and months to do an audit on this useless company,if you want to call it one.Bankruptsy is next,I've kissed my money goodbye months ago! The Tsxv is home to many companies like this!

<< Previous

Bullboard Posts

Next >>

Rig Count Soars as Utilization Surpasses Industry Averages